Effective "activated PI3K delta syndrome"-targeted therapy with the PI3Kd inhibitor leniolisib

VK Rao, S Webster, V.A.S.H. Dalm, A Sediva, P.M. van Hagen, S Holland, SD Rosenzweig, AD Christ, B Sloth, M Cabanski, AD Joshi, S de Buck, J Doucet, D Guerini, C Kalis, I Pylvaenaeinen, N Soldermann, A Kashyap, G Uzel, MJ LenardoDD Patel, CL Lucas, C Burkhart

Research output: Contribution to journalArticleAcademicpeer-review

148 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2307-2316
Number of pages10
Issue number21
Publication statusPublished - 2017

Cite this